​

ADMA Biologics Ownership | Who Owns ADMA Biologics?

OverviewForecastRevenueFinancialsChartTranscripts

ADMA Biologics Ownership Summary

ADMA Biologics is owned by 19.77% institutional investors, 2.57% insiders, and 77.66% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 14.75% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.95% of its assets in ADMA Biologics shares.

ADMA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockADMA Biologics19.77%2.57%77.66%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de35.63M14.75%$522.36M
Vanguard group20.97M8.69%$307.49M
Blackrock18.64M8.15%$208.45M
State street13.56M5.62%$198.81M
Invesco12.51M5.18%$183.33M
Sachem head capital management lp8.96M3.71%$131.35M
Geode capital management5.81M2.41%$85.24M
Nuveen5.72M2.37%$83.92M
Westfield capital management co lp5.11M2.11%$74.87M
Dimensional fund advisors lp4.80M1.99%$70.34M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
B group2.41M26.02%$35.37M
Stonepine capital management739.00K8.81%$10.83M
Caligan partners lp2.64M5.06%$38.65M
Sachem head capital management lp8.96M3.71%$131.35M
Awm investment company2.20M3.02%$32.25M
Ranger investment management2.34M2.39%$34.32M
Ophir asset management pty1.26M2.27%$18.40M
Catalio capital management, lp684.51K1.86%$10.03M
First turn management808.67K1.78%$11.86M
Marathon capital management466.57K1.57%$6.84M

Top Buyers

HolderShares% AssetsChange
Sachem head capital management lp8.96M3.71%8.96M
Westfield capital management co lp5.11M0.31%5.11M
Capital research global investors3.25M0.01%3.25M
Caligan partners lp2.64M5.06%2.64M
State street13.56M0.01%1.48M

Top Sellers

HolderShares% AssetsChange
Fmr732.66K0.00%-2.48M
Driehaus capital management---2.48M
D. e. shaw3.07M0.04%-2.20M
Nuveen asset management4.55M0.02%-2.03M
Vaughan nelson investment management---1.80M

New Positions

HolderShares% AssetsChangeValue
Sachem head capital management lp8.96M3.71%8.96M$131.35M
Westfield capital management co lp5.11M0.31%5.11M$74.87M
Capital research global investors3.25M0.01%3.25M$47.70M
Caligan partners lp2.64M5.06%2.64M$38.65M
Pfm health sciences, lp1.18M1.33%1.18M$17.31M

Sold Out

HolderChange
Mendota financial group-4.00
Global financial private client-24.00
Physician wealth advisors-25.00
Aquatic capital management-27.00
Stephens consulting-60.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025154-58.93%47,734,498-76.76%190.27%60-74.36%68-33.98%
Jun 30, 20253764.16%204,872,1710.17%841.15%23018.56%107-6.96%
Mar 31, 20253578.51%204,309,7520.18%851.14%192-4.00%1139.71%
Dec 31, 20243213.55%200,305,365-3.74%851.09%1961.55%992.06%
Sep 30, 202430920.23%208,056,49715.00%881.42%19329.53%9618.52%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF14.20M5.95%-
Vanguard US Total Market Shares ETF7.15M3.01%281.42K
Vanguard Total Stock Mkt Idx Inv7.17M3.01%-150.89K
iShares Russell 2000 ETF5.58M2.34%-
SPDR® S&P Biotech ETF3.25M1.36%7.24K
Xtrackers MSCI World Swap ETF 1C2.97M1.24%-
CREF Stock R12.80M1.20%-102.61K
Vanguard Small Cap Index2.75M1.15%-18.30K
American Century Small Cap Growth Inv2.62M1.10%447.92K
American Century U.S. Small Cap Growth2.62M1.10%447.92K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 19, 2025Grossman Adam S President and CEOSell$240.00K
Nov 19, 2025Grossman Adam S President and CEOSell$96.00K
Oct 24, 2025Grossman Adam S President and CEOSell$96.00K
Oct 24, 2025Grossman Adam S President and CEOSell$240.00K
Sep 15, 2025Grossman Adam S President and CEOSell$96.78K

Insider Transactions Trends

DateBuySell
2025 Q4-4
2025 Q3-6
2025 Q2-13
2025 Q1-2
2024 Q4-2

ADMA Ownership FAQ

Who Owns ADMA Biologics?

ADMA Biologics shareholders are primarily institutional investors at 19.77%, followed by 2.57% insiders and 77.66% retail investors. The average institutional ownership in ADMA Biologics's industry, Biotech Stocks , is 45.24%, which ADMA Biologics falls below.

Who owns the most shares of ADMA Biologics?

ADMA Biologics’s largest shareholders are Blackrock funding, inc. /de (35.63M shares, 14.75%), Vanguard group (20.97M shares, 8.69%), and Blackrock (18.64M shares, 8.15%). Together, they hold 31.59% of ADMA Biologics’s total shares outstanding.

Does Blackrock own ADMA Biologics?

Yes, BlackRock owns 8.15% of ADMA Biologics, totaling 18.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 208.45M$. In the last quarter, BlackRock increased its holdings by 445.43K shares, a 2.45% change.

Who is ADMA Biologics’s biggest shareholder by percentage of total assets invested?

B group is ADMA Biologics’s biggest shareholder by percentage of total assets invested, with 26.02% of its assets in 2.41M ADMA Biologics shares, valued at 35.37M$.

Who is the top mutual fund holder of ADMA Biologics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ADMA Biologics shares, with 5.95% of its total shares outstanding invested in 14.2M ADMA Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools